Inventor

JANUSZ MICHAEL J

US10 patents

⚠️ This page may combine multiple inventors who share the name “JANUSZ MICHAEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AVENTIS PHARMA INC

5 patents

US6352976B1Mar 5, 2002

Selective inhibitors of MMP-12

AVENTIS PHARMA INC14 citations83

US6770640B1Aug 3, 2004

1-Carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of MMP-12

AVENTIS PHARMA INC12 citations73

US6544980B2Apr 8, 2003

N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase

AVENTIS PHARMA INC2 citations51

US6329550B1Dec 11, 2001

Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase

AVENTIS PHARMA INC1 citations51

US6953788B1Oct 11, 2005

3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase

AVENTIS PHARMA INC0 citations40

MERRELL PHARMA INC

1 patent

US5510333AApr 23, 1996

Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation

MERRELL PHARMA INC29 citations92

BRIGHAM & WOMENS HOSPITAL

1 patent

US5057503AOct 15, 1991

Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor

BRIGHAM & WOMENS HOSPITAL56 citations90

AVANTIS PHARMACEUTICALS INC

1 patent

US6262080B1Jul 17, 2001

3-(thio-substitutedamido)-lactams useful as inhibitors of matrix metalloproteinase

AVANTIS PHARMACEUTICALS INC6 citations57

JANUSZ MICHAEL J

1 patent

USD270171SAug 16, 1983

Set of game playing pieces

JANUSZ MICHAEL J4 citations55

MERRELL DOW PHARMA

1 patent

US5384119AJan 24, 1995

Method of preventing neutrophil mediated connective tissue damage

MERRELL DOW PHARMA1 citations50